Roivant Sciences's total assets for Q4 2023 were $7.22B, a decrease of -1.23% from the previous quarter. ROIV total liabilities were $773.95M for the fiscal quarter, a 6.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.